Updated research emailed to shareholders.
FY19: EBITDA - $9.6m, EPS (post minorities) $0.07
FY20: EBITDA - $14.5m, EPS (post minorities) $0.097
FY21: EBITDA - $18.1m, EPS (post minorities) $0.123
- Forums
- ASX - By Stock
- HLA
- Cannacord updated research - target price $1.45
Cannacord updated research - target price $1.45
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online